Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Mesoblast Limited
  6. News
  7. Summary
    MSB   AU000000MSB8

MESOBLAST LIMITED

(MSB)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

08/31/2021 | 09:14am EDT


ę MT Newswires 2021
All news about MESOBLAST LIMITED
10/08MESOBLAST : REXLEMESTROCEL-L PHASE 3 TRIAL RESULTS IN CHRONIC HEART FAILURE SELECTED AS LA..
PU
10/06MESOBLAST : Rexlemestrocel-L Phase 3 Trial Results in Chronic Heart Failure Selected as La..
GL
10/06Mesoblast Limited Announces Rexlemestrocel-L Phase 3 Trial Results in Chronic Heart Fai..
CI
10/01MESOBLAST : Management Team
PU
09/02Australian shares rise on miners, energy boost
RE
09/02BHP : Australian shares end at 2-week low as BHP tumbles on ex-div trade
RE
09/01MESOBLAST : OPERATIONAL HIGHLIGHTS AND FINANCIAL RESULTS FOR THE YEAR ENDED JUNE 30, 2021 ..
PU
09/01Australia shares trim losses on better-than-expected GDP data
RE
09/01NOVARTIS : Mesoblast Deal On Cell Therapy Drags As US FDA Raises Manufacturing Concerns
MT
08/31Banks, miners drive Australian shares lower ahead of GDP data
RE
More news
Analyst Recommendations on MESOBLAST LIMITED
More recommendations
Financials
Sales 2022 40,7 M 30,2 M 30,2 M
Net income 2022 -113 M -84,0 M -84,0 M
Net cash 2022 17,4 M 12,9 M 12,9 M
P/E ratio 2022 -7,54x
Yield 2022 -
Capitalization 1 037 M 770 M 770 M
EV / Sales 2022 25,0x
EV / Sales 2023 11,7x
Nbr of Employees 83
Free-Float 85,6%
Chart MESOBLAST LIMITED
Duration : Period :
Mesoblast Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MESOBLAST LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 1,60 AUD
Average target price 2,68 AUD
Spread / Average Target 67,2%
EPS Revisions
Managers and Directors
Silviu Itescu Chief Executive Officer, MD & Executive Director
Andrew Chaponnel Chief Financial Officer & Head-Finance
Joseph R. Swedish Independent Non-Executive Chairman
Fred Grossman Chief Medical Officer
Dagmar Rosa-Bjorkeson Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
MESOBLAST LIMITED-28.89%770
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414